长期使用质子泵抑制剂所致高胃泌素血症及其对策

中国临床药理学与治疗学 ›› 2006, Vol. 11 ›› Issue (12): 1321-1325.

• 综述 • 下一篇

长期使用质子泵抑制剂所致高胃泌素血症及其对策

沈健, 吴建新, 李定国

上海交通大学医学院附属新华医院消化内科, 上海200092

收稿日期:2006-06-26 修回日期:2006-09-18 出版日期:2006-12-26 发布日期:2020-11-06
通讯作者: 吴建新,男, 教授, 主任医师, 主要从事消化系统疾病的基础和临床研究。Tel:021-65790000-7103 E-mail:wjxgp@sh163.net
作者简介:沈健, 男, 硕士研究生, 住院医师, 主要研究方向:先天性黄疸。Tel:021-65790000-7104 E-mail:amazan88@hotmail.com

Sequelae of hypergastrinemia due to long-term administration of proton pumPinhibitors and its management

SHEN Jian, WU Jian-xin, LI Ding-guo

Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092,China

Received:2006-06-26 Revised:2006-09-18 Online:2006-12-26 Published:2020-11-06

摘要/Abstract

摘要： 质子泵抑制剂的应用是酸相关疾病的标准治疗。但是, 长期使用对胃食管反流征患者可能存在潜在危害, 例如低酸反馈所致的高胃泌素血症, 肠嗜银细胞的增殖, 潜在的胃部肿瘤诱发作用, 停药后的酸反跳, 幽门螺杆菌感染者胃泌酸区胃炎发生率增加, 高胃泌素血症所致的其它肿瘤等。人们正在研究这些潜在危害, 评价长期使用质子泵抑制剂的风险-效益比, 并提出对应策略。

关键词: 质子泵抑制剂, 高胃泌素血症, 消化道肿瘤

Abstract: Proton pumPinhibitor (PPI) is considered as the standard treatment for acid-related disorders.However,its long-term use, especially in patients with gastroesophageal reflux disease, would cause potential risks,such as hypergastrinemia along with reduced gastric acidity,hyperplasia of enterochromaffin cells (ECL), gastric neoplasms, rebound gastric acid hypersecretion when PPI treatment is stopped, increased oxyntic gastritis in patients with H.pylori infection, and the possible stimulation of growth of non-gastric tumours due to hypergastrinaemia.Each of these trends has led to numerous studies and evaluations on the potential risk-benefit ratio of the long-term use of PPIs, and countermeasures are being proposed for these problems.

Key words: proton pumPinhibitor, hypergastrinemia, gastrointestinal neoplasms

中图分类号:

R969

沈健, 吴建新, 李定国. 长期使用质子泵抑制剂所致高胃泌素血症及其对策[J]. 中国临床药理学与治疗学, 2006, 11(12): 1321-1325.

SHEN Jian, WU Jian-xin, LI Ding-guo. Sequelae of hypergastrinemia due to long-term administration of proton pumPinhibitors and its management[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(12): 1321-1325.

参考文献

1 Jensen RT.Consequences of long-term proton pumPblockade:insights from studies of patients with gastrinomas[J].Basic Clin Pharmcol Tox, 2006;98:4-19
2 Rindi G, Fiocca R, Morocutti A, Jacobs A, Miller N, Thjodleifsson B, et al.Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa[J].Eur J Gastroenterol Hepatol, 2005;17:559-66
3 Klotz U, Schwab M, Treiber G.CYP2C19 polymorphism and proton pumPinhibitors[J].Basic Clin Pharmcol Tox, 2004;95:2-8
4Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, Snel P, Goldfain D, Kolkman JJ, et al.Cure of Helicobacter pylori infection in patients with refluxs oesophagitis treated with long-term omeprazole reverses gastritis without exacerbation of reflux disease:results of randomized controlled trial[J].Gut, 2004;53:12-20
5Fossmark R, Johnsen G, Johanessen E, Waldum HL.Rebound acid hypersecretion after long-term inhibition of gastric acid secretion[J].Sliment Parmacol Ther, 2005;21:149-54
6 McColl KE.Helicobacter pylori infection and long term proton pumPinhibitor therapy[J].Gut, 2004;53:57
7 Qvigstad G, Waldum H.Rebound hypersecretion after inhibition of gastric acid secretion[J].Basic Clin Pharmacol Toxicol,2004;94:202-8
8 Geboes K, Dekker W, Mulder CJ, Nusteling K, Dutch Study Group.Long-term lansoprazole treatment for gastro-oesophageal reflux disease:clinical efficacy and influence on gastric mucosa[J].Aliment Pharmacol Ther, 2001;15:1189-826
9 Klinkenberg-Knol EC, Nelis F, Dent J, Snel P, Mitchell B,Prichard P, et al.Long-term omeprazole treatment in resistant gastroesophageal reflux disease:efficacy, safety, and influence on gastric mucosa[J].Gastroenterology, 2000;118:661-9
10 Uemura N, Okamoto S, Yamamoto SH.Pylori infection and the development of gastric cancer[J].Keio JMed, 2002;51:63-8
11 Flejou JF.Barrett' s oesophagus:from metaplasia to dysplasia and cancer[J].Gut, 2005;54:6-12
12 Peghini PL, Annibale B, Azzoni C, Milione M, Corleto VD,Gibril F, et al.Effect of chronic hypergastrinemia on human enterchromaffin-like cells:insight from patients with sprodiac gastrinomas[J].Gastroenterology, 2002;123:68-85
13 Smith AM, Watson SA.Gasrtin and gastrin receptor activation:an early event in the adenoma-carcinoma sequence[J].Gut,2000;47:820-4
14 Waldum HL, Gustafsson B, Fossmark R, Qvigstad G.Antiulcer drugs and gastric cancer[J].Dig Dis Sci, 2005;50:S39-44
15 Watson SA, Morris TM, McWilliams DF, Harris J, Evans S,Smith A, et al.Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence[J].Br J Cancer, 2002;87:567-73
16 Raghunath AS, O' Morain C, McLoughlin RC.Review article:the Chin J Clin Pharmacol Ther 2006 Dec;11(12)long-term use of proton-pumPinhibitors[J].Aliment Pharmacol Ther, 2005;22:55-63
17 Lassen A, Hallas J, Schaffalitzky de Muckadell OB.Use of antisecretory medication:a population-based cohort study[J].Aliment Pharmacol Ther, 2004;20:577-83
18 Lassen A, Hallas J, de Muckadell OB.Eradication of Helicobacter pylori and use of antisecretory drugs:population based cohort study[J].BMJ, 2003;327:603
19 Jacobson BC, Ferris TG, Shea TL, Mahlis EM, Lee TH,Wang TC.Who is using chronic acid suppression therapy and why[J] ? Am J Gastroenterol, 2003;98:51-8
20 Bateman DN, Colin-Jones D, Hartz S, Langman M, Logan RF, Mant J, et al.Mortality study of 18 000 patients treated with omeprazole[J].Gut, 2003;52:942-6
21 Bour B, Staub JL, Chousterman M, Labayle D, Nalet B, Nouel O, et al.Long-term treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole:on-demand treatment compared with continuous treatment[J].Aliment Pharmacol Ther, 2005;21:805-12
22 Fennerty MB.Review article:alternative approaches to the long-term management of GERD[J].Aliment Pharmacol Ther,2005;22:39-44

[1]	赵世峰，汪荣华. 新型抑酸药物钾离子竞争型酸阻滞剂研发进展[J]. 中国临床药理学与治疗学, 2018, 23(3): 352-360.
[2]	陆亚君，黄晓颖，傅中明. 铝碳酸镁联合PPI治疗COPD合并咽喉反流的疗效及对AECOPD的预防作用[J]. 中国临床药理学与治疗学, 2018, 23(11): 1270-1275.
[3]	黄琼，杜洁，成舒乔，龚志成. 癌症患者质子泵抑制剂使用的研究进展[J]. 中国临床药理学与治疗学, 2018, 23(10): 1179-1187.
[4]	翟蒙蒙，李志刚，沈杰，王凤丽，谷宁，杨娜. 质子泵抑制剂对进展期胃癌化疗方案临床疗效的影响[J]. 中国临床药理学与治疗学, 2017, 22(8): 933-936.

长期使用质子泵抑制剂所致高胃泌素血症及其对策

Sequelae of hypergastrinemia due to long-term administration of proton pumPinhibitors and its management

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 4

编辑推荐

Metrics

本文评价